Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 20/20 | 0.77 |
| ▸ | JAK3 | P52333 | 20/20 | 0.77 |
| ▸ | SYK | P43405 | 1/20 | 0.76 |
| ▸ | JAK2 | O60674 | 9/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | TYK2 | P29597 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15392287 | 0.88 | JAK1 (0.73) | JAK1JAK3SYKJAK2CYP3A4 | |
| SCHEMBL15908235 | 0.87 | JAK1 (1.00) | JAK1JAK3SYKJAK2CYP3A4 | |
| SCHEMBL341635 | 0.87 | JAK1 (0.79) | JAK1JAK3SYKJAK2CYP3A4 | |
| SCHEMBL341199 | 0.87 | JAK1 (0.79) | JAK1JAK3SYKJAK2CYP3A4 | |
| SCHEMBL340382 | 0.84 | JAK1 (0.81) | JAK1JAK3SYKJAK2CYP3A4 | |
| SCHEMBL341375 | 0.83 | JAK1 (0.82) | JAK1JAK3SYKJAK2CYP3A4 | |
| SCHEMBL341097 | 0.83 | JAK1 (0.73) | JAK1JAK3SYKJAK2CYP3A4 | |
| SCHEMBL1741339 | 0.83 | JAK1 (0.65) | JAK1JAK3SYKJAK2CYP3A4 | |
| SCHEMBL340415 | 0.82 | JAK1 (0.78) | JAK1JAK3SYKJAK2CYP3A4 | |
| SCHEMBL339846 | 0.82 | JAK1 (0.78) | JAK1JAK3SYKJAK2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2389372-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | Rigel Pharmaceuticals, Inc. (US) | 2011-11-30 | — | — | EP | claimed |
| US-8037782-B2 | Steering column assembly | FUJI KIKO CO., LTD. (JP) | 2011-10-18 | — | — | US | claimed |
| WO-2010085684-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | RIGEL PHARMACEUTICALS, INC. (US) | 2010-07-29 | — | — | WO | claimed |
| WO-2013173506-A2 | METHOD OF TREATING MUSCULAR DEGRADATION | RIGEL PHARMACEUTICALS, INC. (US) | 2013-11-21 | — | — | WO | disclosed |
| EP-2389372-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | Rigel Pharmaceuticals, Inc. (US) | 2011-11-30 | — | — | EP | disclosed |
| US-8037782-B2 | Steering column assembly | FUJI KIKO CO., LTD. (JP) | 2011-10-18 | — | — | US | disclosed |
| WO-2010085684-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | RIGEL PHARMACEUTICALS, INC. (US) | 2010-07-29 | — | — | WO | disclosed |